SPF 30 Sunscreen Lotion

Drug Labeling and Warnings

Drug Details [pdf]

SUNSCREEN - octinoxate, octisalate, oxybenzone, titanium dioxide lotion 
Crown Products, LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

SPF 30 Sunscreen Lotion

Active Ingredient

Octinoxate 7.5%, Octisalate 2.0%, Oxybenzone 4%, Titanium Dioxide 2.5%

Purpose

Sunscreen

Uses

Helps prevent sunburn

Warnings

For external use only.

When using this product

Avoid contact with eyes. In case of eye contact, flush with plenty of water.

Stop use and ask a doctor

if irritation or redness develops.

Keep out of reach of chilren

If swallowed, get medical help or contact a Poison Control Center

Directions

Apply generously and evenly before sun exposure. Reapply as needed after towel drying, swimming, or sweating. Ask a doctor before using on children under 6 months.

Other information

Sun Alert: Limiting sun exposure and using sunscreens may reduce the risk of skin aging, skin cancer, and other harmful effects of the sun.

Inactive Ingredients

Water, Cetearyl Alcohol, Xanthan Gum, C12-15 Alkyl Benzoate, Myristyl Propionate, Propylene Glycol, Glyceryl Stearate, Disodium EDTA, Glycerin, Ceteareth-25, Disodium Ethlene Dicocamide PEG-15 Disulfate, Dimethicone, Fragrance

Distributed by: CROWN PRODUCTS, LLC

Mobile, AL 36606 * 1-251-665-3627

MADE IN CHINA



SPF 30 Sunscreen Lotion

UVA and UVB Protection


Active Ingredient
Octinoxate 7.5%, Octisalate 2.0%, Oxybenzone 4%, Titanium Dioxide 2.5%

Purpose
Sunscreen

Sunscreen Lotion

SUNSCREEN 
octinoxate, octisalate, oxybenzone, titanium dioxide lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 52675-030
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE7.5 mL  in 100 mL
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE2.0 mL  in 100 mL
OXYBENZONE (UNII: 95OOS7VE0Y) (OXYBENZONE - UNII:95OOS7VE0Y) OXYBENZONE4.0 mL  in 100 mL
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE2.5 mL  in 100 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
XANTHAN GUM (UNII: TTV12P4NEE)  
ALKYL (C12-15) BENZOATE (UNII: A9EJ3J61HQ)  
MYRISTYL PROPIONATE (UNII: P59053E7NJ)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
GLYCERIN (UNII: PDC6A3C0OX)  
CETEARETH-25 (UNII: 8FA93U5T67)  
DISODIUM ETHYLENE DICOCAMIDE PEG-15 DISULFATE (UNII: QI9A6U005W)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 52675-030-1515 mL in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart35205/14/2012
Labeler - Crown Products, LLC (034018234)

Revised: 5/2012
 

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.